Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

@article{Verbruggen2020GuidanceRC,
  title={Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group},
  author={Lisanne C. Verbruggen and Yuehan Wang and S. Armenian and M. Ehrhardt and H. J. van der Pal and E. C. van Dalen and Jorrit W van As and E. Bardi and Katja Baust and C. Berger and E. Castagnola and K. Devine and J. Gebauer and J. G. Marchak and A. Glaser and A. Groll and G. Haeusler and Jaap den Hartogh and R. Haupt and L. Hjorth and M. Kato and T. Kepak and Maria M W Rianne Koopman and T. Langer and M. Maeda and G. Michel and M. Muraca and P. Nathan and Selina R van den Oever and V. Pavasovic and Satomi Sato and F. Schulte and L. Sung and W. Tissing and A. Uyttebroeck and R. Mulder and C. Kuehni and R. Skinner and M. Hudson and L. Kremer},
  journal={Pediatric Blood & Cancer},
  year={2020}
}
  • Lisanne C. Verbruggen, Yuehan Wang, +37 authors L. Kremer
  • Published 2020
  • Medicine
  • Pediatric Blood & Cancer
  • Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID‐19. Little is known about the clinical course of COVID‐19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for… CONTINUE READING
    5 Citations

    References

    SHOWING 1-10 OF 44 REFERENCES
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    • 79
    • PDF